Since the first description of oncogenes over 25 years ago (Stehelin et al., 1976), there has been tremendous progress in our understanding of the roles different genes play in the oncogenesis process ...

Oligonucleotides are short sequences of nucleotides. Oligonucleotides are small, synthetic nucleic acid subsections that are fundamental in current molecular biology, acting as tools in gene ...

The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

Oligonucleotide therapeutics make up a small but rapidly growing segment of the overall global drug pipeline, with 245 programs currently in development today. While only one approved oligo ...

Antisense oligonucleotides are essentially short, single-stranded synthetic fragments of DNA or RNA that bind specifically to the target RNA sequence inside cells and modulate protein expression ...

The global oligonucleotide API market is poised to grow from USD 2.81 billion in 2024 to USD 4.84 billion by 2034, expanding at a CAGR of 5.60%. The increasing need for innovative drug classes and ...

Table 5.1: Global Oligonucleotide Synthesis Market Size, By Product, $Million (2018-2029) Table 5.2: Global Synthesized Oligonucleotides Market Size, By Region ...